These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 18465677)

  • 1. Deals landscape: notable deals in the pharmaceutical industry in the first quarter of 2008.
    Shumoogam J; Al-Shamahi A
    IDrugs; 2008 May; 11(5):351-5. PubMed ID: 18465677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting monoclonal antibody mega-deals.
    Villiger R; Bogdan B
    MAbs; 2009; 1(2):172-8. PubMed ID: 20061828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deals landscape: notable deals in the pharmaceutical industry in the second quarter of 2008.
    Bright J; Lakeram M
    IDrugs; 2008 Aug; 11(8):584-91. PubMed ID: 18724496
    [No Abstract]   [Full Text] [Related]  

  • 4. Sanofi takeover jeopardizes Aventis biotech deals.
    Mitchell P
    Nat Biotechnol; 2004 Jun; 22(6):639-40. PubMed ID: 15175667
    [No Abstract]   [Full Text] [Related]  

  • 5. Deals landscape: notable deals in the pharmaceutical industry in the third quarter of 2008.
    Glah D; Tear S
    IDrugs; 2008 Nov; 11(11):841-5. PubMed ID: 19024888
    [No Abstract]   [Full Text] [Related]  

  • 6. Outlook: finding improved medicines: the role of academic-industrial collaboration.
    Chin-Dusting J; Mizrahi J; Jennings G; Fitzgerald D
    Nat Rev Drug Discov; 2005 Nov; 4(11):891-7. PubMed ID: 16247439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notable deals in the pharmaceutical industry in the first quarter of 2017.
    Cruces E
    Drugs Today (Barc); 2017 Jun; 53(6):357-365. PubMed ID: 28799581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways across the valley of death: novel intellectual property strategies for accelerated drug discovery.
    Rai AK; Reichman JH; Uhlir PF; Crossman C
    Yale J Health Policy Law Ethics; 2008; 8(1):1-36. PubMed ID: 18564492
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug discovery veers off target.
    Shaffer C
    Drug Discov Today; 2005 Nov; 10(22):1489. PubMed ID: 16257367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
    Scattereggia J
    IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notable licensing deals in the biopharma industry in the second quarter of 2017.
    D'Souza P
    Drugs Today (Barc); 2017 Aug; 53(8):453-458. PubMed ID: 29119150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategic groups in the biopharmaceutical industry: implications for performance.
    Erden Z; von Krogh G; Nytorp C; Hultberg M
    Drug Discov Today; 2009 Aug; 14(15-16):726-30. PubMed ID: 19416760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The state of innovation in drug development.
    Kola I
    Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
    Hedner T; Gatenbeck L
    Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257
    [No Abstract]   [Full Text] [Related]  

  • 15. Pfizer slashes R&D.
    Cressey D
    Nature; 2011 Feb; 470(7333):154. PubMed ID: 21307908
    [No Abstract]   [Full Text] [Related]  

  • 16. Notable deals in the pharmaceutical industry in the first quarter of 2016.
    Cruces E
    Drugs Today (Barc); 2016 Aug; 52(8):453-459. PubMed ID: 27722213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deal watch: Ablynx and Merck Serono collaborate on next-generation antibody products.
    Nat Rev Drug Discov; 2008 Nov; 7(11):881. PubMed ID: 18974745
    [No Abstract]   [Full Text] [Related]  

  • 18. Notable deals in the pharmaceutical industry in the third quarter of 2016.
    Cruces E
    Drugs Today (Barc); 2016 Oct; 52(10):569-575. PubMed ID: 27910965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notable deals in the pharmaceutical industry in the second quarter of 2016.
    D'Souza P
    Drugs Today (Barc); 2016 Aug; 52(8):461-465. PubMed ID: 27722214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notable deals in the pharmaceutical industry in the fourth quarter of 2016.
    D'Souza P
    Drugs Today (Barc); 2017 Jan; 53(1):75-82. PubMed ID: 28387386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.